Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 May 2021 | Story André Damons | Photo Sonia Small (Kaleidoscope Studios)
Mr Godfrey Mahlatsi, Acting Head of the Free State Department of Health; Ms Montseng Tsiu, Free State MEC of Health; Ms Sisi Ntombela, Premier of the Free State; and Prof Francis Petersen, Rector and Vice-Chancellor, give the thumbs up to the vaccination centre at the Universitas Academic Hospital.

As a public institution, the University of the Free State (UFS) always wants to play a role in society through its expertise, facilities, and assets. It is for this reason that the university is assisting the Free State Department of Health to equip the vaccination centre at the Universitas Academic Hospital to function optimally as one of the primary vaccination sites in Bloemfontein. 

Prof Francis Petersen, Rector and Vice-Chancellor, says the university decided to assist the department by providing computers, chairs, tables, and installing network cables at the vaccination centre which opened on Monday May 24 2021. The recovery room where patients are monitored after being vaccinated was also equipped. The university’s School of Nursing is also training its students to help with the vaccination process. 

Prof Petersen, together with Prof Gert van Zyl, Dean of the Faculty of Health Sciences; Ms Sisi Ntombela, Premier of the Free State; Ms Montseng Tsiu, MEC of Health; and Mr Godfrey Mahlatsi, Acting Head of the Department of Health, paid a visit to the vaccination centre on Tuesday 25 May 2021. 

UFS part of the broader community 

“The UFS is a public institution and we always ask what our role in society is. We are part of the broader community so we need to play a role through our expertise, our facilities, and assets and see to what extent we can positively impact the community. This is a good example of doing that. COVID-19 is an opportunity for everyone to take hands and address it in a collaborative way.

“The UFS values our partners, and in this particular case, the Department of Health. We believe that if we can work with our partners, the impact would be that much greater. If this facility is full to capacity, we would be able to vaccinate about 3 000 people a day which would never have been achieved if we did not take hands,” says Prof Petersen.
According to him, the UFS will do the same in Qwaqwa by providing the same type of equipment. Prof Petersen also encourages South Africans, especially those over the age of 60, to register to be vaccinated. 

“It is also my role as leader of the institution to encourage people to register and get vaccinated, because if you do get COVID-19 again, the impact will be lighter. This is something that we need to fight and manage.”

People are excited to be vaccinated  
Premier Ntombela says the province is lucky to have the UFS as a partner. “The university has been with us since day one. We are very excited and lucky to partner with them. I think they are doing a wonderful job, not only with their expertise, but also with providing equipment for us to use. I am very happy that everything is going smoothly. Everyone wants to be vaccinated and people are excited.”

According to Dr Nicholas Pearce, Head of Surgery at the UFS – who is also heading the Universitas Hospital COVID-19-Task Team – their aim is to vaccinate between 1 500 and 2 000 people a day. “The UFS School of Nursing is busy training nursing students to assist us with vaccinating people. The university’s contribution is massive. We would not be able to do it without them,” says Dr Pearce. 

WATCH video:


News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept